Erick Bermúdez-Méndez

Mr. Erick Bermúdez-Méndez

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2018 in Toxins
Verified
Journal Article
Open access
PDF file
EBErick Bermúdez-Méndez
Erick Bermúdez-Méndez
AFAlbert Fuglsang-Madsen
Albert Fuglsang-Madsen
SFSofie Føns
Sofie Føns
Bruno LomonteBruno Lomonte
Bruno Lomonte
José María GutiérrezJosé María Gutiérrez
José María Gutiérrez
Andreas LaustsenAndreas Laustsen
Andreas Laustsen
Snakes, scorpions, and spiders are venomous animals that pose a threat to human health, and severe envenomings from the bites or stings of these animals must be treated with antivenom. Current antivenoms are based on plasma-derived immunoglobulins or immunoglobulin fragments from hyper-immunized animals. Although these medicines have been life-saving for more than 120 years, opportunities to improve envenoming therapy exist. In the later decades, new biotechnological tools have been applied with the aim of improving the efficacy, safety, and affordability of antivenoms. Within the avenues explored, novel immunization strategies using synthetic peptide epitopes, recombinant toxins (or toxoids), or DNA strings as immunogens have demonstrated potential for generating antivenoms with high therapeutic antibody titers and broad neutralizing capacity. Furthermore, these approaches circumvent the need for venom in the production process of antivenoms, thereby limiting some of the complications associated with animal captivity and venom collection. Finally, an important benefit of innovative immunization approaches is that they are often compatible with existing antivenom manufacturing setups. In this review, we compile all reported studies examining venom-independent innovative immunization strategies for antivenom development. In addition, a brief description of toxin families of medical relevance found in snake, scorpion, and spider venoms is presented, as well as how biochemical, bioinformatic, and omics tools could aid the development of next-generation antivenoms.

21 April 2020 in eLife
Verified
Journal Article
Open access
PSPaul Wichgers Schreur
Paul Wichgers Schreur
SWSandra van de Water
Sandra van de Water
MHMichiel Harmsen
Michiel Harmsen
EBErick Bermúdez-Méndez
Erick Bermúdez-Méndez
DDDubravka Drabek
Dubravka Drabek
JKJeroen Kortekaas
Jeroen Kortekaas
The World Health Organization has included three bunyaviruses posing an increasing threat to human health on the Blueprint list of viruses likely to cause major epidemics and for which no, or insufficient countermeasures exist. Here, we describe a broadly applicable strategy, based on llama-derived single-domain antibodies (VHHs), for the development of bunyavirus biotherapeutics. The method was validated using the zoonotic Rift Valley fever virus (RVFV) and Schmallenberg virus (SBV), an emerging pathogen of ruminants, as model pathogens. VHH building blocks were assembled into highly potent neutralizing complexes using bacterial superglue technology. The multimeric complexes were shown to reduce and prevent virus-induced morbidity and mortality in mice upon prophylactic administration. Bispecific molecules engineered to present two different VHHs fused to an Fc domain were further shown to be effective upon therapeutic administration. The presented VHH-based technology holds great promise for the development of bunyavirus antiviral therapies.

22 March 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
EBErick Bermúdez-Méndez
Erick Bermúdez-Méndez
EKEugene A. Katrukha
Eugene A. Katrukha
CSCindy M. Spruit
Cindy M. Spruit
JKJeroen Kortekaas
Jeroen Kortekaas
PSPaul Wichgers Schreur
Paul Wichgers Schreur
Bunyaviruses have a genome that is divided over multiple segments. Genome segmentation complicates the generation of progeny virus, since each newly formed virus particle should preferably contain a full set of genome segments in order to disseminate efficiently within and between hosts. Here, we combine immunofluorescence and fluorescence in situ hybridization techniques to simultaneously visualize bunyavirus progeny virions and their genomic content at single-molecule resolution in the context of singly infected cells. Using Rift Valley fever virus and Schmallenberg virus as prototype tri-segmented bunyaviruses, we show that bunyavirus genome packaging is influenced by the intracellular viral genome content of individual cells, which results in greatly variable packaging efficiencies within a cell population. We further show that bunyavirus genome packaging is more efficient in insect cells compared to mammalian cells and provide new insights on the possibility that incomplete particles may contribute to bunyavirus spread as well.

15 November 2022 in PLOS Biology
Verified
Journal Article
Open access
PDF file
EBErick Bermúdez-Méndez
Erick Bermúdez-Méndez
KBKirsten F. Bronsvoort
Kirsten F. Bronsvoort
MZMark Zwart
Mark Zwart
SWSandra van de Water
Sandra van de Water
ICIngrid Cárdenas-Rey
Ingrid Cárdenas-Rey
PSPaul Wichgers Schreur
Paul Wichgers Schreur
Bunyaviruses lack a specific mechanism to ensure the incorporation of a complete set of genome segments into each virion, explaining the generation of incomplete virus particles lacking one or more genome segments. Such incomplete virus particles, which may represent the majority of particles produced, are generally considered to interfere with virus infection and spread. Using the three-segmented arthropod-borne Rift Valley fever virus as a model bunyavirus, we here show that two distinct incomplete virus particle populations unable to spread autonomously are able to efficiently complement each other in both mammalian and insect cells following co-infection. We further show that complementing incomplete virus particles can co-infect mosquitoes, resulting in the reconstitution of infectious virus that is able to disseminate to the mosquito salivary glands. Computational models of infection dynamics predict that incomplete virus particles can positively impact virus spread over a wide range of conditions, with the strongest effect at intermediate multiplicities of infection. Our findings suggest that incomplete particles may play a significant role in within-host spread and between-host transmission, reminiscent of the infection cycle of multipartite viruses.

29 June 2023 in Journal of Virology
Verified
Journal Article
Open access
EBErick Bermúdez-Méndez
Erick Bermúdez-Méndez
PAPaolo Angelino
Paolo Angelino
LKLucien van Keulen
Lucien van Keulen
SWSandra van de Water
Sandra van de Water
BRBarry Rockx
Barry Rockx
PSPaul Wichgers Schreur
Paul Wichgers Schreur
Rift Valley fever virus (RVFV) is a mosquito-transmitted pathogen capable of causing severe disease in animals and humans. Outbreaks of RVFV pose a significant threat to public health and can result in substantial economic losses.

4 September 2020 in Research Square
Verified
Preprint
Open access
PDF file
EBErick Bermúdez-Méndez
Erick Bermúdez-Méndez
EKEugene Katrukha
Eugene Katrukha
CSCindy Spruit
Cindy Spruit
JKJeroen Kortekaas
Jeroen Kortekaas
PSPaul Wichgers Schreur
Paul Wichgers Schreur
Bunyaviruses have a genome that is divided over multiple segments. Genome segmentation complicates the generation of progeny virus, since each newly formed virus particle should preferably contain a full set of genome segments in order to disseminate efficiently within and between hosts. Here, we combine immunofluorescence and fluorescence in situ hybridization techniques to simultaneously visualize bunyavirus progeny virions and their genomic content at single-molecule resolution in the context of singly infected cells. Using Rift Valley fever virus and Schmallenberg virus as prototype tri-segmented bunyaviruses, we show that bunyavirus genome packaging is influenced by the intracellular viral genome content of individual cells, which results in greatly variable packaging efficiencies within a cell population. We further show that bunyavirus genome packaging is more efficient in insect cells compared to mammalian cells and provide new insights on the possibility that incomplete particles may contribute to bunyavirus spread as well.